SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a significant $1 million insider purchase by director Lawrence Cheng and the company's fiscal second-quarter earnings report, which highlighted a surge in collectibles sales and improved profitability. While the community remains divided between bullish sentiment regarding the company's cash position and potential future catalysts, many traders are actively debating the lack of a formal earnings call and speculating on the timing of further corporate developments.

ServiceTitan, Inc. engages in the collection of field service activities required to install, maintain, and service the infrastructure and systems of residences and commercial buildings. The company was founded by Ara Mahdessian and Vahe Kuzoyan on June 8, 2008 and is headquartered in Glendale, CA.

ServiceTitan Inc. - Ordinary Shares - Class A

ServiceTitan 

ServiceTitan shares declined significantly following fiscal second-quarter results, as investors reacted negatively to a third-quarter revenue guidance miss and the announcement of a chief revenue officer transition. While analysts maintained positive long-term ratings, the conversation is marked by debate over whether the sell-off represents a severe overreaction to minor guidance adjustments or reflects deeper concerns regarding software valuations and competition.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant volatility as traders debate the stock's long-term value against a backdrop of technical fluctuations and concerns over Medicare policy changes. The community is split between bullish sentiment, driven by confidence in the company's defensive position and recent strong financial guidance, and frustration over recent downward price action and institutional manipulation.

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.

Opus Genetics Inc.

Opus Genetics is trending following the release of positive Phase 1/2 clinical data for its gene therapy candidate OPGx-BEST1 and confirmation of alignment with the FDA for potential Phase 3 dosing in 2027. Traders and the community are reacting to the clinical progress, with some debate regarding financial health and past dilution history.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares are trending higher following an optimistic update at the Citi Global TMT Conference, where management raised its long-term AI infrastructure revenue projections and signaled strong demand for upcoming GPU products. While traders are debating the stock's high valuation and sensitivity to broader market volatility, bullish sentiment remains strong as investors anticipate accelerated growth in the company's data center and server CPU segments.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores is facing significant downward pressure following its fiscal first-quarter earnings report, where investors reacted negatively to slower same-store sales growth despite a profit and revenue beat. While some traders view the double-digit sell-off as an overreaction and an opportunity to buy, others express concerns over the stock's valuation, lack of raised guidance, and weakening performance trends.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as traders react to the announcement of a multi-billion dollar AI infrastructure investment by Google in Finland, which involves Nokia providing connectivity, alongside news of the stock's upcoming return to the Euro Stoxx 50 index. Community sentiment is largely bullish, with investors focusing on the company's pivot toward AI networking and data center infrastructure, though some participants remain skeptical due to the stock's historical performance.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as investors anticipate upcoming company milestones, including the scheduled second-quarter earnings call and the anticipated rolling New Drug Application submission. Sentiment remains bullish due to strong clinical trial durability data and the company's established pathway toward a 2027 commercial launch.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending amid a parabolic price rally and significant short squeeze dynamics, with many traders framing it as an 'advanced' alternative to Bitcoin due to its privacy features and limited supply. While the community is overwhelmingly bullish, some participants express skepticism, labeling the rapid gains as unsustainable or warning of a potential 'pump and dump.'

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors react to the highly anticipated debut of its first foldable iPhone, with many traders debating the "sell the news" potential following the product launch event. While some community members are bullish on the new product as a long-term growth driver, others express skepticism regarding the high price point and the company's broader AI strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Guggenheim⬆️Top Pick $IDYA&#39;s PT to $57, stays Buy + provided its deep dive overview on the DLL3 landscape/previewed upcoming data for IDE849 (DLL3 TOP1I ADC) in 2H26—provided its R/R-Upside/Downside—updated Peak Sales. 
$AMGN AZN $ABBV ZLAB MRK - DSNKY AZN 
Here&#39;s what Guggenheim said in its note: https://x.com/Quantumup1/status/2097651514823061956?s=20

Guggenheim⬆️Top Pick $IDYA's PT to $57, stays Buy + provided its deep dive overview on the DLL3 landscape/previewed upcoming data for IDE849 (DLL3 TOP1I ADC) in 2H26-provided its R/R-Upside/Downside-updated Peak Sales.$AMGN AZN $ABBV ZLAB MRK - DSNKY AZNGuggenheim said -- Here,... https://t.co/pdMTpmgK6V

X (Formerly Twitter)

quantumup on X (formerly Twitter): "Guggenheim⬆️Top Pick $IDYA's PT to $57, stays Buy + provided its deep dive overview on the DLL3 landscape/previewed upcoming data for IDE849 (DLL3 TOP1I ADC) in 2H26-provided its R/R-Upside/Downside-updated Peak Sale...

Citizens reitd $IDYA Mkt OP-$42 /said -- IDEAYA&#39;s rapid advancement of IDE849 through the clinic is a strong indicator of the company&#39;s conviction in the program. 
$AZN $AMGN ZLAB MRK - DSNKY 
Citizens added—This confidence is supported by findings from Hengrui&#39;s ongoing Chinese Phase 1 study, as well as emerging experience from IDYA&#39;s own open-label, first-in-Western-humans Phase 1 study, for which data are currently undisclosed. 
 
While updated efficacy and durability data from Hengrui at ESMO 2026 and the initial Western dataset in 2H26 remain important catalysts, we view the positive FDA interactions, growing clarity around the registrational strategy, and alignment on a Phase 3 study with a potential accelerated approval pathway as constructive developments for the program. 
 
While the first registrational study focuses on IDE849 monotherapy, IDYA is evaluating combination studies with either PD-1 inhibitor, Imfinzi (durvalumab), from AZN or with internally developed PARG inhibitor, IDE161.

StockTwits Web

Ideaya Biosciences Inc

AstraZeneca PLC

AMGEN Inc.

Quantumup

Abbvie Inc

's PT to $57, stays Buy + provided its deep dive overview on the DLL3 landscape/previewed upcoming data for IDE849 (DLL3 TOP1I ADC) in 2H26—provided its R/R-Upside/Downside—updated Peak Sales. 


 ZLAB MRK - DSNKY AZN 
Here's what Guggenheim said in its note: 